Impax Asset Management Group’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
TIM
Impax Asset Management Group's PFE Position: Q1 2025 in Review
Impax Asset Management Group sold out of Pfizer (PFE) in Q1 2025, closing a stake of 26,867 shares — an estimated $713K sold.
Impax Asset Management Group first reported a position in PFE in Q4 2020 and held it in 16 quarters. The position peaked at $10.4M in Q4 2021. 2,930 funds tracked by Wall St. Rank hold PFE as of Q1 2025.
- Impax Asset Management Group reported no remaining Pfizer position as of Q1 2025 after selling out during the quarter.
- Impax Asset Management Group sold 26,867 Pfizer shares in Q1 2025, an estimated $713K.
- Impax Asset Management Group first reported a position in Pfizer in Q4 2020 and held it in 16 quarters.
- Impax Asset Management Group's Pfizer position peaked at $10.4M in Q4 2021.
- 2,930 funds tracked by Wall St. Rank held Pfizer as of Q1 2025.
Based on Impax Asset Management Group's 13F filing for Q1 2025, filed 29 Apr 2025.